Front Row Advisors’s Neogen NEOG Stock Holding History
Bought
Maintained
Sold
Other funds holding NEOG
CCA
Front Row Advisors's NEOG Position: Q3 2024 in Review
Front Row Advisors sold out of Neogen (NEOG) in Q3 2024, closing a stake of 60 shares — an estimated $938 sold.
Front Row Advisors first reported a position in NEOG in Q4 2017 and held it in 26 quarters. The position peaked at $3K in Q4 2021. 338 funds tracked by Wall St. Rank hold NEOG as of Q3 2024.
- Front Row Advisors reported no remaining Neogen position as of Q3 2024 after selling out during the quarter.
- Front Row Advisors sold 60 Neogen shares in Q3 2024, an estimated $938.
- Front Row Advisors first reported a position in Neogen in Q4 2017 and held it in 26 quarters.
- Front Row Advisors's Neogen position peaked at $3K in Q4 2021.
- 338 funds tracked by Wall St. Rank held Neogen as of Q3 2024.
Based on Front Row Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.